Accessibility Menu
 
MeVis Medical Solutions Ag logo

MeVis Medical Solutions Ag

(ETR) M3V

Current Price$22.80
Market Cap$41.50M
Since IPO (2007)-37%
5 Year-29%
1 Year-14%
1 Month-9%

MeVis Medical Solutions Ag Financials at a Glance

Market Cap

$41.50M

Revenue (TTM)

$16.64M

Net Income (TTM)

$4.30M

EPS (TTM)

$1.74

P/E Ratio

13.11

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$22.80

Volume

214

Open

$22.80

Previous Close

$22.80

Daily Range

$22.80 - $23.00

52-Week Range

$22.60 - $26.80

M3V News

No articles available.

M3V: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MeVis Medical Solutions Ag

Industry

Health Care Technology

Employees

116

CEO

Marcus Kirchhoff

Website

mevis.de

Headquarters

Bremen, 28359, DE

M3V Financials

Key Financial Metrics (TTM)

Gross Margin

35%

Operating Margin

32%

Net Income Margin

27%

Return on Equity

18%

Return on Capital

20%

Return on Assets

13%

Earnings Yield

7.63%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$41.50M

Shares Outstanding

1.82M

Volume

214

Short Interest

0.00%

Avg. Volume

322.934

Financials (TTM)

Gross Profit

$15.69M

Operating Income

$2.34M

EBITDA

$3.43M

Operating Cash Flow

$3.88M

Capital Expenditure

$140.43K

Free Cash Flow

$3.74M

Cash & ST Invst.

$6.52M

Total Debt

$0.00

MeVis Medical Solutions Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$4.22M

-3.8%

Gross Profit

$1.47M

-14.7%

Gross Margin

34.88%

N/A

Market Cap

$41.50M

N/A

Market Cap/Employee

$414.96K

N/A

Employees

100

N/A

Net Income

$1.20M

-9.7%

EBITDA

$878.09K

-25.3%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$6.52M

-0.1%

Accounts Receivable

$2.28M

+1.6%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

12.95%

N/A

Return on Invested Capital

19.89%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

$0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GS9.FH100 Group AB N
$0.13+0.00%
AJ91.DEDocCheck AG
$11.30-2.59%
BNN.DEBRAIN Biotech AG
$2.63+6.05%
MAK.DEMaternus-Kliniken AG
$1.16-13.43%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$171.24-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
EEIQEpicQuest Education Group International
$8.44+2.09%
MARAMara Holdings
$8.58+0.04%

Questions About M3V

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.